AERES Biomedical, Ltd.
About AERES Biomedical
Since 1999 AERES Biomedical, a subsidiary of MRC Technology (MRCT), has been utilizing its world leading expertise in the clinically proven technology of antibody humanization to develop therapeutic antibodies to target all major life threatening and debilitating diseases. AERES has also shared these technologies and skills with its collaborative partners to produce therapeutic antibodies on their behalf.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of AERES Biomedical
News about AERES Biomedical
Here you will find AERES Biomedical, Ltd.
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
